Magnetic stent hyperthermia for esophageal cancer: An in vitro investigation in the ECA-109 cell line

Oncology Reports

Volumn 27, Issue 3, 2012, Pages 791-797

  Liu, Jia Yi ^a,b   Zhao, Ling Yun ^b   Wang, Yu Ying ^b,c   Li, Dan Ye ^a,b   Tao, Dan ^d   Li, Li Ya ^d   Tang, Jin Tian ^a,b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b TSINGHUA UNIVERSITY   (China)

^c BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^d CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

Alternative magnetic field; Esophageal cancer; Magnetic stent hyperthermia; Thermal dose

Indexed keywords

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; ESOPHAGEAL STENT; ESOPHAGUS CARCINOMA; HEATING; HIGH TEMPERATURE; HUMAN; HUMAN CELL; HYPERTHERMIC THERAPY; INTERMETHOD COMPARISON; MAGNETIC STENT HYPERTHERMIA; MAGNETOTHERAPY; METASTASIS INHIBITION; PRIORITY JOURNAL; STENT; TEMPERATURE DEPENDENCE; TEMPERATURE MEASUREMENT; TREATMENT DURATION; WATER BATH HEATING;

APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; ESOPHAGEAL NEOPLASMS; HEATING; HUMANS; HYPERTHERMIA, INDUCED; IN SITU NICK-END LABELING; MAGNETIC FIELDS; MAGNETICS; NECROSIS; NICKEL; STENTS; TEMPERATURE; TITANIUM;

EID: 84863052286     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1603     Document Type: Article

References (18)

1. Wang ZG, Fukazawa T, Nishikawa T, et al: RAD001 offers a therapeutic intervention through inhibition of mTOR as a potential strategy for esophageal cancer. Oncol Rep 23: 1167-1172, 2010.
2. Gockel I, Moehler M, Frerichs K, et al: Co-expression of receptor tyrosine kinases in esophageal adenocarcinoma and squamous cell cancer. Oncol Rep 20: 845-850, 2008.
3. Candeo A and Dughiero F: Numerical FEM models for the planning of magnetic induction hyperthermia treatments with nanoparticles. IEEE Trans Magn 45: 1658-1661, 2009.
4. Johannsen M, Thiesen B, Jordan A, et al: Magnetic fluid hyperthermia (MFH) reduces prostate cancer growth in the orthotopic Dunning R3327 rat model. Prostate 64: 283-292, 2005. (Pubitemid 40980870)
5. Deger S, Taymoorian K, Boehmer D, et al: Thermoradiotherapy using interstitial self-regulating thermoseeds: an intermediate analysis of a phase II trial. Eur Urol 45: 574-580, 2004. (Pubitemid 38481683)
6. Deger S, Boehmer D, Türk I, Roigas J, Budach V, Loening SA: Interstitial hyperthermia using self-regulating thermoseeds combined with conformal radiation therapy. Eur Urol 42: 147-153, 2002.
7. Jordan A, Scholz R, Maier-Hauff K, et al: The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma. J Neurooncol 78: 7-14, 2006. (Pubitemid 43786652)
8. Cherukuri P, Glazer ES and Curley SA: Targeted hyperthermia using metal nanoparticles. Adv Drug Deliv Rev 62: 339-345, 2010.
9. Ito A and Kobayashi T: Intracelluar hyperthermia using magnetic nanoparticles: a novel method for hyperthermia clinical applications. Thermal Med 24: 113-129, 2008.
10. Yambe T, Hori Y, Shiraishi Y, Sekine K and Miyata G: Drinking stent with therapeutic hyperthermia effect for esophageal cancer. Int J Artif Organs 29: 548, 2006.
11. Akiyama S, Kawasaki S, Kodera Y, et al: A new method of thermo-chemotherapy using a stent for patients with esophageal cancer. Surg Today 36: 19-24, 2006. (Pubitemid 43015849)
12. Zhou JM, Li N, Xia QS, et al: Hyperthermia by a nitinol stent in an alternating magnetic field: safety and feasibility in rabbit esophageal cancer. Prog Nat Sci 19: 1713-1719, 2009.
13. Wan XA, Sun GP, Wang H, Xu SP, Wang ZG and Liu SH: Synergistic effect of paeonol and cisplatin on oesophageal cancer cell lines. Dig Liver Dis 40: 531-539, 2008.
14. Pallepati P and Averill-Bates DA: Mild thermotolerance induced at 40 degrees C protects HeLa cells against activation of death receptor-mediated apoptosis by hydrogen peroxide. Free Radic Biol Med 50: 667-679, 2011.
15. Wang XF, Tang JT and Shi LQ: Induction heating of magnetic fluids for hyperthermia treatment. IEEE Trans Magn 46: 1043-1051, 2010.
16. Floren MG, Günther RW and Schmitz-Rode T: Noninvasive inductive stent heating: alternative approach to prevent instent restenosis. Invest Radiol 39: 264-270, 2004. (Pubitemid 38520660)
17. Gerner EW: Thermal dose and time-temperature factors for biological responses to heat shock. Int J Hyperthermia 3: 319-327, 1987.
18. Sato A, Tamura Y, Sato N, et al: Melanoma-targeted chemo-thermo-immuno (CTI)-therapy using N-propionyl-4-S-cysteaminylphenol-magnetite nanoparticles elicits CTL response via heat shock protein-peptide complex release. Cancer Sci 101: 1939-1946, 2010.